
Bioorganic and Medicinal Chemistry Letters p. 881 - 886 (1997)
Update date:2022-08-04
Topics:
Peglion, Jean-Louis
Vian, Joel
Goument, Bertrand
Despaux, Nicole
Audinot, Valerie
Millan, Mark J.
Starting from the structure of the preferential D3 antagonist S 14297 (1), we have prepared a series of cis and trans tetracyclic derivatives of general formula I in order to improve potency and selectivity for D3 receptors. The trans oxazino derivative 2c, showed slightly increased affinity at D3 receptors and double the selectivity for D3 over D2 receptors, in comparison to S 14297. Cis derivatives and compounds where R1 is aralkyl were totally devoid of activity.
View Moreshandong lukang animal & plant drug trading co.,ltd.
Contact:15853765968
Address:floor 9, lukang ,jingying building,#173,taibai building west road,jining city,shandong,china
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
Contact:+86-371-55981030
Address:Room 1571, Macalline Soho, No.1, Shangdu Road, Zhengzhou, Henan
KAIYUAN CHEMICAL COMPANY LIMITED.
website:http://www.kaiyuanchem.com
Contact:+86-22-59891255/66/77
Address:B-2205, Kuangshi International Building, Yingbin Road, XiangLuo Bay Business District, Binhai New area, Tianjin, China.
Shanghai Sungo Technology Chemical Co., Ltd
Contact:0086-21-51385579
Address:Room2010, F/20, Tonghua Plaza, NO 345 Jinxiang Road, Jinqiao Export Processing Zone, Shanghai, 201206 P.R.CHINA
Doi:10.1016/S0014-827X(99)00017-8
(1999)Doi:10.1016/j.poly.2010.12.049
(2011)Doi:10.1016/j.tetlet.2008.03.138
(2008)Doi:10.1039/DT9900002321
(1990)Doi:10.1002/ardp.200400884
(2004)Doi:10.1016/j.bmcl.2011.02.058
(2011)